Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Danish warship sunk by famed British admiral discovered after 225 years - 2Vote In favor of Your Favored Web based Dating Application
- 3Air travelers face higher ticket prices as Iran war drives up oil prices
- 4Which Instax Camera Would it be a good idea for you to Purchase?
- 5Computerized Domains d: A Survey of \Vivid Undertakings\ Computer generated Reality Game
- UN panel says Israel operating 'de facto policy of torture'
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- Pick Your #1 Sort Of Espresso
- What do scientists hope to learn from NASA's historic Artemis 2 moon flyby?
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- Wolf bites woman in a shopping area in Germany's 2nd-biggest city
- AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- Banks for High Fixed Store Rates: Amplify Your Reserve funds
- Mississippi Insight for Jan. 11, 2026
